Optimal Duration of Follow-up for Assessing Antimalarial Efficacy in Pregnancy: A Retrospective Analysis of a Cohort Followed Up Until Delivery on the Thailand–Myanmar Border

BACKGROUND: Follow-up for 28–42 days is recommended by the World Health Organization to assess antimalarial drug efficacy for nonpregnant populations. This study aimed to determine the optimal duration for pregnant women, as no specific guidance currently exists. METHODS: The distributions of time t...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Open Forum Infect Dis
Glavni autori: Saito, Makoto, Mansoor, Rashid, Wiladphaingern, Jacher, Paw, Moo Kho, Pimanpanarak, Mupawjay, Proux, Stephane, Guérin, Philippe J, White, Nicholas J, Nosten, François, McGready, Rose
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2019
Teme:
Major Article
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6602886/
https://ncbi.nlm.nih.gov/pubmed/31281861
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ofid/ofz264
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items